Skip to main navigation

preloader

Overview
News & Events
- News Releases
- Events
Presentations
SEC Filings
Stock Info
- Analyst Coverage
Corporate Governance
Resources & Contact

News Releases

Year

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 2, 2022

Cullinan Oncology Provides Corporate Update and Reports Third Quarter 2022 Financial Results

November 14, 2022

Cullinan Oncology Announces the Appointment of David P. Ryan, M.D. to its Board of Directors

November 2, 2022

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 1, 2022

Cullinan Oncology to Participate in Upcoming Investor Conferences

November 1, 2022

Cullinan Oncology Significantly Increases Ownership Stake in its MICA Subsidiary which Holds Worldwide Rights to Clinical-Stage Novel Monoclonal Antibody CLN-619

October 25, 2022

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 3, 2022

Cullinan Oncology to Participate in the HC Wainwright Global Investment Conference and the Morgan Stanley Healthcare Conference

September 7, 2022

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 1, 2022

Cullinan Oncology Announces Appointment of Jacquelyn Sumer as Chief Legal Officer

August 15, 2022

Pagination

Current page 1
Page 2
Page 3
Page 4
Next page
Last page

Displaying 1 - 10 of 36

Investor Tools

News & Events
- News Releases
- Events

Stock Info
- Stock Quote & Chart

Corporate Governance

Financials & Filings

IR Resources

Copyright © 2022 Cullinan Oncology, Inc.. All rights reserved

Site - Footer

Terms of Use/Privacy